AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • Agile Therapeutics Inc • Pharmaceutical preparations • New Jersey
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of November 22, 2022, by and between AGILE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Alfred Altomari (the “Executive”), collectively referred to as the “parties.”
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (FIRST WARRANT) AGILE THERAPEUTICS, INC.Common Stock Purchase Warrant • March 23rd, 2023 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (this “Warrant”) is entered into as of the Amendment Date set forth above between Agile Therapeutics, Inc., a Delaware corporation (the “Company”) and Perceptive Credit Holdings III, LP (or its assigns, the “Holder”).
SIXTH AMENDMENT TO PROJECT AGREEMENT (DETAILING – FIELD TEAM)Project Agreement • March 23rd, 2023 • Agile Therapeutics Inc • Pharmaceutical preparations
This Sixth Amendment (the “Amendment”) dated January 3, 2023 (the “Effective Date”) is made by and between Syneos Health Commercial Services, LLC, with an office at 500 Atrium Drive, Somerset, N.J. 08873 (“Syneos Health”) and Agile Therapeutics, Inc. with an office located at 500 College Road East, Suite 310, Princeton, New Jersey 08540 (the “Client”). Syneos Health and Client may each be referred to herein as a “Party” and, collectively, as the “Parties.”
